Iontophoresis as a means of delivering antibiotics into allograft bone

Journal of Bone and Joint Surgery - Series B

Volumn 87, Issue 11, 2005, Pages 1568-1574

  Day, Robert E ^a   Megson, S ^b   Wood, D ^c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b Pioneer Valley Private Hospital   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUCLOXACILLIN; GENTAMICIN;

ACCELERATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BIOLOGICAL MODEL; BONE ALLOGRAFT; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG RESPONSE; ELECTRIC POTENTIAL; GRAFT INFECTION; HUMAN; IN VITRO STUDY; INFECTION PREVENTION; INFECTION RISK; IONTOPHORESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIOSTEUM GRAFT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK REDUCTION; SHEEP;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOLOGICAL AVAILABILITY; BONE TRANSPLANTATION; FLOXACILLIN; GENTAMICINS; HUMANS; IONTOPHORESIS; SHEEP; SURGICAL WOUND INFECTION; TIBIA;

EID: 28444437681     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.87B11.16384     Document Type: Article

References (32)

1. Clohisy DR, Mankin HJ. Osteoarticular allografts for reconstruction after resection of a musculoskeletal tumor in the proximal end of the tibia. J Bone Joint Surg [Am] 1994;76-A:549-54.
2. Delloye C, De Nayer P, Allington N, et al. Massive bone allografts in large skeletal defects after tumor surgery: a clinical and microradiographic evaluation. Arch Orthop Trauma Surg 1988;107:31-41.
3. Jofe MH, Gebbardt MC, Tomford WW, Makin HJ. Reconstruction for defects of the proximal part of the femur using allograft arthroplasty. J Bone Joint Surg [Am] 1988;70-A:507-16.
4. Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WW. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop 1996;324:86-97.
5. Musculo DL, Ayerza MA, Calabrese ME, Gruenberg M. The use of a bone allograft for reconstruction after resection of giant-cell tumor close to the knee. J Bone Joint Surg [Am] 1993:75-A:1656-62.
6. Dion N, Sim FH. The use of allografts in orthopaedic surgery. Part I: the use of allografts in musculoskeletal oncology. J Bone Joint Surg [Am] 2002;84-A:644-54.
7. Alexeef M, Mahomed N, Morsi E, Garbuz D, Gross A. Structural allograft in two-stage revisions for failed septic hip arthroplasty. J Bone Joint Surg [Br] 1996;78-B:213-16.
8. Berrey BH Jr, Lord CF, Gebhardt MC, Mankin HJ. Fractures of allografts: frequency, treatment and end-results. J Bone Joint Surg [Am] 1990;72-A:825-33.
9. Edwards SA, Pandit HG, Grover ML, Clarke HJ. Impaction bone grafting in revision hip surgery. J Arthroplasty 2003;18:852-9.
10. Haddad FS, Garbuz DS, Masri BA, Duncan CP. Structural proximal femoral allografts for failed total hip replacements: a minimum review of five years. J Bone Joint Surg [Br] 2000;82-B:830-6.
11. Toms AD, Barker RL, Jones RS, Kuiper JH. Impaction bone-grafting in revision joint replacement surgery. J Bone Joint Surg [Am] 2004;86-A:2050-60.
12. Chan Y-S, Ueng SW-N, Wang C-J, et al. Management of small infected tibial defects with antibiotic-impregnated autogenic cancellous bone grafting. J Trauma 1998;45:758-64.
13. Lord CF, Gebhardt MC, Tomford WW, Mankin HJ. Infection in bone allografts: incidence, nature and treatment. J Bone Joint Surg [Am] 1988;70-A:369-76.
14. Cara JA, Lacleriga A, Canadell J. Intercalary bone allografts: 23 tumour cases followed for 3 years. Acta Orthop Scand 1994;65:42-6.
15. Dick HM, Strauch RJ. Infection of massive bone allografts. Clin Orthop 1994;306:46-53.
16. McGann W, Mankin HJ, Harris WH. Massive allografting for severe failed total hip replacement. J Bone Joint Surg [Am] 1986;68-A:4-12.
17. Mankin HJ, Doppelt S, Tomford WW. Clinical experience with allograft implantation: the first ten years. Clin Orthop 1983:174:69-86.
18. Licht S. History of electrotherapy. In: Stillwell GK, ed. Therapeutic electricity and ultraviolet radiation. Baltimore: Williams & Wilkins, 1983:1.
19. Singh P, Maibach H. Iontophoresis in drug delivery: basic principles and applications. Crit Rev Ther Drug Carrier Syst 1994:11:161-213.
20. Trissel LA. Handbook of injectable drugs. Twelfth ed. Bethseda: American Society of Hospital Pharmacists, 2003.
21. Tomford WW, Thongphasuk J, Mankin HJ, Ferraro MJ. Frozen musculoskeletal allografts: a study of the clinical incidence and causes of infection associated with their use. J Bone Joint Surg [Am] 1990;72-A:1137-43.
22. Gebhardt MC, Flugstad DI, Springfield DS, Mankin HJ. The use of bone allografts for limb salvage in high-grade extermity osteosarcoma. Clin Orthop 1991; 270:181-96.
23. Witso E, Persen L, Loseth K, Bergh K. Adsorption and release of antibiotics from morselized cancellous bone: in vitro studies of 8 antibiotics. Acta Orthop Scand 1999; 70:298-304.
24. Witso E, Persen L, Benum P, Bergh K. Release of netilmicin and vancomycin from cancellous bone. Acta Orthop Scand 2002;73:199-205.
25. Winkler H, Janata O, Berger C, Wien W, Georgopoulos A. In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother 2000;46:423-8.
26. Li XD, Hu YY. The treatment of osteomyelitis with gentamicin-reconstituted bone xenograft-composite. J Bone Joint Surg [Br] 2001;83-B:1063-8.
27. Miclau T, Dahners LE, Lindsey RW. In vitro pharmacokinetics of antibiotic release from locally implantable materials. J Orthop Res 1993;11:627-32.
28. Petri WH 3rd, Schaberg SJ. The effects of antibiotic-supplemented bone allografts on contaminated, partially avulsive fractures of the canine ulna. J Oral Maxillofac Surg 1984;42:699-704.
29. Petri WH 3rd, Wilson TM. Clinical evaluation of antibiotic-supplemented bone allograft. J Oral Maxillofac Surg 1993;51:982-5.
30. Leigh D, Marriner J, Nisbet D, et al. Bone concentrations of cefuroxime and cegamandole in the femoral head in 96 patients undergoing total hip replacement surgery. J Antimicrob Chemother 1982;9:303-11.
31. Henry SL, Galloway KP. Local antibacterial therapy for the management of orthopaedic infections: pharmocokinetic considerations. Clin Pharmacokinet 1995;29: 36-45.
32. van de Belt H, Neut D, Schenk W, et al. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. Acta Orthop Scand 2001;72:557-71.